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achieved  from  his  parents,  he  had  no  otalgia  or  otorrheaIntroduction
Langerhans  cells  (LCs)  are  antigen  presenting  dendritic  cells
found  in  epidermis,  respiratory  and  genital  epithelia.1 In
1953,  Lichenstein  introduced  the  term  eosinophilic  granu-
loma,  Hand--Schuller--Christian  disease  and  Letterer--Siwe
disease  which  are  characterized  by  clonal  proliferation  of
LCs.  In  1985  Philadelphia  Workshop  of  the  Histiocyte  soci-
ety  adapted  the  term  langerhans  cell  histiocytosis  (LCH)  to
gather  these  different  synonyms  under  one  term.2
LCH  is  a  very  rare  disease  seen  in  approximately  one  case
per  2  million  children,  males  are  more  frequently  affected
than  females,  and  presenting  age  varies  between  a  few
months  to  15  years  with  a  peak  incidence  of  1--4  years.1 This
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esion  or  multisystem  involvement,  temporal  bone  involve-
ent  occurs  in  19--25%  of  cases,  with  bilateral  involvement
n  1/3  of  these  ones.1 In  the  case  of  ear  involvement  most
ommon  symptoms  are  chronic  ear  discharge  resistant  to
ntibiotic  treatment,  postauricular  swelling,  hearing  loss,
talgia  and  temporo-zygomatic  mass.  Facial  nerve  paralysis
s  a  very  rare  ﬁnding  in  LCH  with  an  average  incidence  of
.8%.3
In  this  case  presentation,  we  demonstrated  a  LCH  patient
ith  facial  paralysis  as  initial  symptom.
ase report
ritten  consent  was  taken  from  the  patient’s  parents  for
his  case  presentation.
An otherwise  healthy  2  years  old  male  patient  was  con-
ulted  from  pediatric  emergency  department  with  acute
nset  peripheral  facial  nerve  palsy.  According  to  the  historyomplaint.  In  the  morning  after  he  woke  up,  his  parents
ealized  that  he  could  not  close  his  left  eye  during  cry-
ng.  On  his  physical  examination  otoscopic  ﬁndings  revealed
 Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
enses/by/4.0/).
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Figure  1  Axial  computed  tomography  image  at  bone  window
shows a  mass  (open  arrow)  within  the  left  mastoid  air  cells  with
a
a
f
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arrowing  of  the  external  ear  canal  from  the  posterior  part
y  a  mass  originating  from  the  mastoid  bone.  Tympanic
embrane  was  hardly  seen  and  a  bluish  color  mass  was
resent  on  the  middle  ear.  He  had  left  House--Brackmann
rade  IV  peripheral  facial  nerve  paralysis.  Cranial  tomo-
raphy  revealed  a  mass  comprising  left  mastoid  air  cells,
xtending  to  the  middle  ear  (Fig.  1).  Magnetic  resonance
maging  of  the  temporal  bone  demonstrated  a  solid,  densely
ontrast  enhancing  hypointense  mass  which  obliterates  the
astoid  air  cells  and  extends  into  posterior  part  of  inner
ar  without  intracranial  involvement  (Fig.  2).  Mastoidec-
omy  and  biopsy  from  the  mass  was  performed  under
eneral  anesthesia.  Pathological  investigation  showed  inﬁl-
ration  with  tumoral  cells  having  oval  orthochromic  nucleus.
mmunohistochemical  staining  demonstrated  positive  stain-
ng  with  CD1a  and  S100  antigens  (Fig.  3).  The  diagnosis  was
ell  consistent  with  LCH.  After  Pediatric  Hematology  and
ncology  consultation,  systemic  evaluation  was  performed
ith  abdominopelvic,  neck,  thoracic  tomography  and  whole
ody  bone  scintigraphy.  There  were  metastatic  foci  in
andibula  and  calvarium  including  parietal  bone  and  vertex
n  bone  scintigraphy.  Seven  cycles  of  chemotherapy  regimen
ncluding  Vinblastin  (Vinko® 1  mg/mL.  Koc¸ak  Farma  drug-
stanbul-Turkey)  and  oral  prednisolone  (Deltacortil® 5  mg.
ﬁzer  drug-˙Istanbul-Turkey)  treatment  were  administered.
n  the  control  imaging  studies  there  was  half  shrinkage  of  the
rimary  tumor  and  there  was  decrement  in  radioactive  Tc-
9m  intensity  in  mandibular  and  calvarium  metastases.  The
atient’s  left  facial  paralysis  was  completely  recovered  after
reatment.  The  patient  is  still  followed  up  with  Pediatric
ematology  and  Oncology  department.iscussion
angerhans  cell  histiocytosis  is  characterized  by  pathog-
omonic  LC  proliferation  which  are  histiocytes  normally
h
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t
igure  2  Axial  T2-weighted  magnetic  resonance  image  (A)  demon
avity. Postcontrast  T1-weighted  image;  (B)  reveals  homogeneous  enn extension  into  the  middle  ear  cavity  (white  arrow).  Note  the
ssociated  cortical  erosion  at  the  mastoid  bone  (black  arrow).
ound  in  dermis.  Etiology  of  LCH  is  unknown,  variable
ypotheses  such  as  neoplastic,  immunologic  or  inﬂammatory
rocesses  are  investigated  but  still  there  is  no  proof  explain-
ng  the  exact  pathogenesis.  LCH  is  not  familial  or  hereditary,
here  is  no  race  predominance.  The  disease  is  mostly  seen  in
strates  a  hypointense  mass  (arrow)  occupying  the  left  mastoid
hancement  within  the  mass  (arrow).
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CFigure  3  (A)  Arrows  show  tumor  cells  which  were  positively  s
were positively  stained  with  S100  (S100,  400×).
ﬂat  bones  of  children  such  as  ribs,  pelvis,  scapula  and  skull.
Temporal  bone  involvement  is  rare.4
When  temporal  bone  involvement  presents  in  LCH,  a
great  suspicion  is  needed  to  correctly  diagnose  this  rare  dis-
ease,  because  sign  and  symptoms  are  non-speciﬁc  and  they
mimic  more  common  diseases  of  the  ear  such  as  suppura-
tive  otitis  media,  chronic  otitis  media,  aural  polyps,  simple
otitis  externa  and  acute  mastoiditis.  Common  presenting
symptoms  are  postauricular  swelling,  chronic  otorrhea,  otal-
gia,  hearing  loss  and  bleeding.  Involvement  of  the  inner  ear
and  sensorineural  hearing  loss  are  less  common  presenting
symptoms  due  to  compact  nature  of  petrous  apex  and  otic
capsule.4
Differential  diagnosis  of  pediatric  peripheral  Facial  Nerve
Paralysis  (FNP)  is  broad  including  Bell’s  palsy,  infections  like
acute  otitis  media,  trauma,  congenital  anomalies  and  rarely
malignancies.  Most  of  the  cases  are  acquired  rather  than
congenital  and  number  of  cases  is  much  less  (5--21/100,000)
when  compared  to  adult  patients.  Tumors  account  for  2--12%
of  all  pediatric  facial  nerve  paralysis  cases.  The  most  com-
mon  types  are  leukemias,  teratomas,  soft  tissue  sarcomas
and  neuroblastoma.5 Although  LCH  involves  temporal  bone
in  19--25%  of  cases,  with  bilateral  involvement  in  1/3  of
these  ones,1 facial  nerve  paralysis  is  a  very  rare  ﬁnding.  In
the  series  of  Nicollas  et  al.6 with  42  patients,  Surico  et  al.2
with  34  patients,  McCaffrey  et  al.7 with  22  patients,  Fer-
nández  Latorre  et  al.8 with  14  cases,  Abdel-Aziz  et  al.4 with
12  patients,  and  Saliba  et  al.3 with  10  patients,  none  of  the
patients  had  facial  nerve  paralysis  as  initial  symptom  or  in
the  course  of  the  disease.  In  the  most  broad  serie,  almost
50  years  ago,  Tos9 presented  only  2.8%  of  facial  paralysis
in  500  patients  of  LCH  patients.  In  1993  Goldsmith  et  al.10
presented  a  case  of  petrous  apex  LCH  with  FNP.  The  lower
rate  of  facial  nerve  paralysis  than  expected  for  LCH  cases
with  temporal  involvement  may  be  due  to  the  tumor’s  hav-
ing  a  lower  afﬁnity  to  the  neural  structures.  Facial  palsy  can
arise  from  compromised  blood  supply  due  to  destruction  of
the  osseous  canal  rather  than  direct  invasion.9
For  the  diagnosis  of  LCH,  pathological  investigation  of
the  biopsy  specimen  is  mandatory.  For  biopsy  achievement
in  cases  of  temporal  bone  involvement,  a  mastoidectomy  is
mostly  required  like  our  case.3 In  the  pathological  investiga-
tion  LCs  have  abundant  vacuolated  cytoplasm  with  vesicular
oval  intended  nuclei.  Light  microscopy  is  insufﬁcient  for
deﬁnitive  diagnosis.  Electron  microscopy  shows  immature
A
f
td  with  CD1a  (CD1a,  400×).  (B)  Arrows  show  tumor  cells  which
Cs  with  characteristic  pentalaminar  organelles  called  as
irbeck  granules.  But  since  electron  microscopy  is  not  cost
ffective,  histopathological  diagnosis  is  mostly  achieved  by
mmunohistochemical  staining.  Tumor  cells  are  positively
tained  with  surface  antigen  S-100  and  leukocyte  adhesion
olecules  CD1  antigens  like  in  the  case  of  our  patient.3
For  treatment  options  of  temporal  bone  LCH  cases  there
s  a great  variability  between  authors.  Surgery,  radiation
herapy,  chemotherapy  and  combination  of  these  treatment
ptions  exist.  In  the  current  treatment  options  most  of
he  authors  agree  that  surgery  must  be  chosen  for  tumors
hich  can  be  totally  excised.  Chemotherapy  is  helpful  in
ultifocal  disease  and  must  be  preferred  when  surgical
otal  removal  could  not  be  achieved.3 Stereotactic  radio-
urgery  and  intralesional  corticosteroid  treatment  options
re  other  treatment  alternatives  that  can  be  applied.4 For
he  chemotherapy  protocol  stage  of  the  tumor  is  important.9
ccording  to  LCH  study  group,  LCH  I  protocol  consists
f  vinblastine  +  prednisone,  is  applied  for  cases  of  single
ystem-multifocal,  or  multisystem  disease.  LCH  II  protocol
dds  etoposide  to  LCH  I  protocol  for  multisystem  dis-
ase  with  risk  of  organ  dysfunction.  LCH  III  protocol  adds
ethotrexate  to  two  drug  treatment  for  cases  of  multi-
ystem  disease  and  organ  dysfunction,  the  LCH  I  is  the
ost  widely  used  protocol.4 There  is  no  globally  accepted
reatment  option  for  all  temporal  bone  LCH  cases  due  to
carcity  of  number  of  patients.  Since  our  case  had  a  sin-
le  system-multifocal  tumor  with  temporal,  calvarial  bones
nd  mandibular  involvement,  we  preferred  chemotherapy
ncluding  LCH  I  protocol  for  our  treatment  option.  Surgery
as  not  performed  except  for  biopsy  procedure,  since  the
umor  was  not  amenable  to  total  excision.  In  the  follow-up
eriod,  facial  paralysis  totally  recovered  with  LCH  I  protocol
hemotherapy  for  our  case.
The  prognosis  of  LCH  is  dependent  on  the  stage  of  disease
nd  age  of  the  patient.  Age  lower  than  2  years,  multisystem
isease  and  organ  dysfunction  are  bad  prognostic  factors  for
CH  cases.3
onclusions  a  conclusion,  for  children  with  acute  onset  peripheral
acial  paralysis,  langerhans  cell  histiocytosis  must  also  be
hought  in  differential  diagnosis.  Treatment  plan  must  be
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ade  after  imaging  studies  for  determining  widespread
f  the  disease  with  a  multidisciplinary  approach  including
torhinolaryngologist,  Pediatric  Oncologist  and  Radiologist.
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